Influenza A (H1N1) outbreak and challenges for pharmacotherapy

Indian Journal of Physiology and Pharmacology

Volumn 53, Issue 2, 2009, Pages 113-126

  Chawla, Raman ^a   Sharma, Rakesh Kumar ^a   Bhardwaj, Janak Raj ^b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b National Disaster Management Authority   (India)

Author keywords

Antigenic recycling; Antiviral drugs vaccines; Influenza A (H1N1); Pandemic

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; SIALIDASE INHIBITOR; ZANAMIVIR;

ANTIGENIC MODULATION; ANTIVIRAL RESISTANCE; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG INDICATION; DRUG MARKETING; DRUG MECHANISM; EPIDEMIC; GENETIC REASSORTMENT; GOVERNMENT REGULATION; HEALTH CARE PLANNING; HEALTH PROMOTION; HUMAN; INDIA; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A H1N1; LABORATORY DIAGNOSIS; MORBIDITY; MORTALITY; NONHUMAN; PANDEMIC; PROTECTIVE EQUIPMENT; PUBLIC HEALTH; REVIEW; SWINE INFLUENZA; VACCINE PRODUCTION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS LATENCY; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS TRANSMISSION; VIRUS VIRULENCE; WORLD HEALTH ORGANIZATION;

ANTIVIRAL AGENTS; CIVIL DEFENSE; DISASTER PLANNING; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; GOVERNMENT REGULATION; HEALTH POLICY; HOSPITAL RAPID RESPONSE TEAM; HUMANS; INDIA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ORGANIZATIONAL OBJECTIVES; PROGRAM DEVELOPMENT; QUARANTINE; TIME FACTORS; VIRULENCE; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 73249128585     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Lamb RA, Krug RM In: BN Fields, DM Knipe, PM Howley (editors) Orthomyxoviridae: the viruses and their replication- Fields Virology. Lippincott-Raven, Philadelphia 1996; pp. 1353-1445.
2. Wang C, Takeuchi K, Pinto LH et al. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. Journal of Virology 1993; 67: 5585-5594.
3. Parsai G. No threat to food chain: FAO. The Hindu, April, 2009, Delhi.
4. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 2008; 26: D49-D53.
5. Kimura H, Abiko C, Peng G et al. Interspecies transmission of Influenza C virus between humans and pigs. Virus Res 1997; 48: 71-79.
6. Matsuzaki Y, Sugawara K, Mizuta K et al. Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996 and 1998. J Clin Microbiol 2002; 40: 422-429.
7. Murphy BR, Sly DL, Tierney EL et al. Reassortant virus derived from avian and human influenza A viruses is attenuated and immunogenic in monkeys. Science 1982; 218: 1330-1332.
8. Lopez AD, Chin B, Feehan D et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918"20 pandemic: a quantitative analysis. The Lancet 2006; 368: 2211-2218.
9. World health group issues alert Mexican president tries to isolate those with swine flu. Associate Press. April 25, 2009. www.jsonline.com/news/ usandworld/43705182.html.
10. Gaydos JC, Top FH, Hodder RA et al. Swine influenza a outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Diseases 2006; 12: 23-28.
11. Gregg MB, Hinman AR, Craven RB. The Russian flu. Its history and implications for this year's influenza season. JAMA 1978; 240: 2260-2263.
12. Harder TC, Werner O. Avian Influenza. In: B.S. Kamps, C. Hoffman, W. Preiser (editors) Influenza Report 2006. Flying Publisher, Paris, France 2001; pp. 1-225.
13. Nancy C. Carvajal, TJ Burgonio. Checkpoints set up to seize contaminated meat from Bulacan. The Philippine Daily Inquirer 2007.
14. Lynch JP, Walsh EE. Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med 2007; 28: 144-158.
15. Kay RM, Done SH, Paton DJ. Effect of sequential porcine reproductive and respiratory syndrome and swine influenza on the growth and performance of finishing pigs. Vet Rec 1994; 135: 199-204.
16. WHO updates on H1 N1 virus outbreak (27th April, 2009 onwards) - 1-20 updates http://www.who.int/csr/en/
17. Riley S, Wu JT, Leung GM. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate. PLoS Med 2007; 4: e218.
18. Centre for Disease Control, USA- Recommendations for Swine Flu. http://www.cdc.gov/swineflu/ recommendations.htm
19. National Disaster Management Guidelines-Management of Biological Disasters, 2008. A publication of National Disaster Management Authority, Government of India. ISBN 978-81-906483-6-3, July, 2008, New Delhi.
20. Timpka T, Eriksson H, Gursky EA et al. Population-based simulations of influenza pandemics: validity and significance for public health policy. Bull World Health Organ 2009; 87: 305-311.
21. Bright RA, Shay DK, Shu B et al. Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States. J Amer Med Assoc 2006; 295: 891-894.
22. Proceedings of the International Workshop on "Pandemic Preparedness Beyond Health' held in April, 2008, a publication of National Disaster Management Authority, New Delhi.
23. Alok A, Chhaparia P. Firms to be told to stock swine flu drugs. NEWS -Apr 28, 2009; 2225 hrs IST, New Delhi.
24. Reason, New York Times. This Season's Flu Virus Is Resistant tor 2 Standard Drugs By Altman Publisher, 2006.
25. Zampaglione M. "Press Release: A/H1N1 influenza like human illness in Mexico and the USA: OIE statement". World Organisation for Animal Health. http://www.oie.int/eng/press/ en-090427.htm. Retrieved on April 29, 2009.